Reduced DNA-dependent protein kinase activity in two cell lines derived from adult cancer patients with late radionecrosis

Oncogene

Volumn 23, Issue 32, 2004, Pages 5562-5566

  Loong, Susan L E ^a,b   Korzh, Svitlana ^b   Price, Allan ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

DNA dependent protein kinase; Radiation injury; Radiosensitivity

Indexed keywords

DNA DEPENDENT PROTEIN KINASE; DOUBLE STRANDED DNA; KU ANTIGEN;

ARTICLE; ATAXIA TELANGIECTASIA; CELL IMMORTALIZATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; DNA REPAIR; DNA STRAND BREAKAGE; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; IRRADIATION; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RADIATION DOSE; RADIATION NECROSIS; RADIOSENSITIVITY;

DNA; DNA REPAIR; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES;

HUMAN HERPESVIRUS 4;

EID: 3843128691     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207771     Document Type: Article

References (23)

1. Alapetite C, Thirion P, de la Rochefordiere A, Cosset JM and Moustacchi E. (1999). Int. J. Cancer, 83, 83-90.
2. Allalunis-Turner J, Lintott LG, Barron GM, Day RS and Lees-Miller SP. (1995a). Cancer Res., 55, 5200-5202.
3. Allalunis-Turner J, Zia PK, Barron GM, Mirzayans R and Day III RS. (1995b). Radiat. Res., 144, 288-293.
4. Alsbeih G, Malone S, Lochrin C, Girard A, Fertil B and Raaphorst GP. (2000). Int. J. Radiat. Oncol. Biol. Phys., 46, 143-152.
5. Bjork-Eriksson T, West CM, Karlsson E, Slevin NJ, Davidson SE, James RD and Mercke C. (1998). Br. J. Cancer, 77, 2371-2375.
6. DiBiase SJ, Zeng ZC, Chen R, Hyslop T, Curran Jr WJ and Iliakis G. (2000). Cancer Res., 60, 1245-1253.
7. Godsen CM, Davidson C and Robertson M. (1986). Human Cytogenetics A Practical Approach, Rooney DE, Czepulowski BH (eds). IRL Press: Oxford, pp. 31-54.
8. Herring CJ, West CM, Wilks DP, Davidson SE, Hunter RD, Berry P, Forster G, MacKinnon J, Rafferty JA, Elder RH, Hendry JH and Margison GP. (1998). Br. J. Cancer, 78, 1128-1133.
9. Iliakis G. (1991). Bioessays, 13, 641-648.
10. Manley JL, Fire A, Samuels M and Sharp PA. (1983). Methods Enzymol., 101, 568-582.
11. O'Driscoll M, Cerosaletti KM, Girard PM, Dai Y, Stumm M, Kysela B, Hirsch B, Gennery A, Palmer SE, Seidel J, Gatti RA, Varon R, Oettinger MA, Neitzel H, Jeggo PA and Concannon P. (2001). Mol. Cell, 6, 1175-1185.
12. Polischouk AG, Cedervall B, Ljungquist S, Flygare J, Hellgren D, Grenman R and Lewensohn R. (1999). Int. J. Radiat. Oncol. Biol. Phys., 43, 191-198.
13. Price P and McMillan TJ. (1990). Cancer Res., 50, 1392-1396.
14. Safwat A, Bentzen SM, Turesson I and Hendry JH. (2002). Int. J. Radiat. Oncol. Biol. Phys., 52, 198-204.
15. Sirzen F, Nilsson A, Zhivotovsky B and Lewensohn R. (1999). Eur. J. Cancer, 35, 111-116.
16. Stewart GS, Maser RS, Stankovic T, Bressan DA, Kaplan MI, Jaspers NG, Raams A, Byrd PJ, Petrini JH and Taylor AM. (1999). Cell, 99, 577-587.
17. Taalman RD, Jaspers NG, Scheres JM, de Wit J and Hustinx TW. (1983). Mutat. Res., 112, 23-32.
18. Taylor AM, Harnden DG, Arlett CF, Harcourt SA, Lehmann AR, Stevens S and Bridges BA. (1975). Nature, 258, 427-429.
19. Tucker SL, Geara FB, Peters LJ and Brock WA. (1996). Radiother. Oncol., 38, 101-113.
20. West CM, Davidson SE, Elyan SE, Swindell R, Roberts SA, Orton CJ, Coyle CA, Valentine H, Wilks DP, Hunter RD and Hendry JH. (1998). Int. J. Radiat. Biol., 73, 409-413.
21. West CM, Davidson SE, Roberts SA and Hunter RD. (1997). Br. J. Cancer, 76, 1184-1190.
22. Woods T, Wang W, Convery E, Errami A, Zdzienicka MZ and Meek K. (2002). Nucleic Acids Res., 19, 5120-5128.
23. Zhao HJ, Hosoi Y, Miyachi H, Ishii K, Yoshida M, Nemoto K, Takai Y, Yamada S and Suzuki N. (2000). Clin. Cancer Res., 6, 1073-1078.